Evidence map›Paper›PMID 35277543›Full record

ArticleScientific reports2022

Micro-Fourier-transform infrared reflectance spectroscopy as tool for probing IgG glycosylation in COVID-19 patients.

Carla Carolina Silva Bandeira, Karen Cristina Rolim Madureira, Meire Bocoli Rossi, Juliana Failde Gallo, Ana Paula Marques Aguirra da Silva, Vilanilse Lopes Torres, Vinicius Alves de Lima, Norival Kesper Júnior, Janete Dias Almeida, Rodrigo Melim Zerbinati and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Carla Carolina Silva BandeiraCentro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, SP, 09210-580, Brazil.
Karen Cristina Rolim MadureiraInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Meire Bocoli RossiInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Juliana Failde GalloInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Ana Paula Marques Aguirra da SilvaInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Vilanilse Lopes TorresInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Vinicius Alves de LimaInstituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, 05403-000, Brazil.
Norival Kesper JúniorInstituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, 05403-000, Brazil.
Janete Dias AlmeidaDepartamento de Biociências e Diagnêstico, Instituto de Ciência e Tecnologia, Universidade Estadual Paulista, São José dos Campos, SP, 12245-000, Brazil.
Rodrigo Melim ZerbinatiInstituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, 05403-000, Brazil.
Paulo Henrique Braz-SilvaInstituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, 05403-000, Brazil.
José Angelo Lauletta LindosoInstituto de Infectologia Emilio Ribas, São Paulo, Sp, 01246-900, Brazil.
Herculano da Silva MartinhoCentro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, SP, 09210-580, Brazil. herculano.martinho@ufabc.edu.br.
Instituto de Infectologia Emílio Ribas · BRUniversidade de São Paulo · BRUniversidade Federal do ABC · BRFundação Faculdade de Odontologia · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 307718/2019-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 311146/2015-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2011/19924-2
6 · The paper itself

Abstract

It has been reported that patients diagnosed with COVID-19 become critically ill primarily around the time of activation of the adaptive immune response. However the role of antibodies in the worsening of disease is not obvious. Higher titers of anti-spike immunoglobulin IgG1 associated with low fucosylation of the antibody Fc tail have been associated to excessive inflammatory response. In contrast it has been also reported that NP-, S-, RBD- specific IgA, IgG, and IgM are not associated with SARS-CoV-2 viral load, indicating that there is no obvious correlation between antibody response and viral antigen detection. In the present work the micro-Fourier-transform infrared reflectance spectroscopy (micro-FTIR) was employed to investigate blood serum samples of healthy and COVID-19-ill (mild or oligosymptomatic) individuals (82 healthcare workers volunteers in "Instituto de Infectologia Emilio Ribas", São Paulo, Brazil). The molecular-level-sensitive, multiplexing quantitative and qualitative FTIR data probed on 1 µL of dried biofluid was compared to signal-to-cutoff index of chemiluminescent immunoassays CLIA and ELISA (IgG antibodies against SARS-CoV-2). Our main result indicated that 1702-1785 [Formula: see text] spectral window (carbonyl C=O vibration) is a spectral marker of the degree of IgG glycosylation, allowing to probe distinctive sub-populations of COVID-19 patients, depending on their degree of severity. The specificity was 87.5 % while the detection rate of true positive was 100%. The computed area under the receiver operating curve was equivalent to CLIA, ELISA and other ATR-FTIR methods ([Formula: see text]). In summary, overall discrimination of healthy and COVID-19 individuals and severity prediction as well could be potentially implemented using micro-FTIR reflectance spectroscopy on blood serum samples. Considering the minimal and reagent-free sample preparation procedures combined to fast (few minutes) outcome of FTIR we can state that this technology is suitable for fast screening of immune response of individuals with COVID-19. It would be an important tool in prospective studies, helping investigate the physiology of the asymptomatic, oligosymptomatic, or severe individuals and measure the extension of infection dissemination in patients.

Indexed as

AdultAntibodies, ViralCOVID-19COVID-19 TestingEnzyme-Linked Immunosorbent AssayFemaleGlycosylationHumansImmunoglobulin GLuminescent MeasurementsMaleMiddle AgedPatient AcuityReproducibility of ResultsSARS-CoV-2Sensitivity and SpecificityAntibodies, ViralImmunoglobulin G

Identifiers

PMID35277543
PMCPMC8914452
OpenAlexW4220988613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.